Press Releases

August 31, 2018 Lupin receives FDA approval for generic Potassium Chloride Oral Solution USP

August 28, 2018 Lupin receives FDA approval for generic Gabapentin Tablets USP, 600 mg and 800 mg

August 27, 2018 Lupin launches generic Drospirenone, Ethinyl Estradiol, Levomefolate Calcium Tablets and Levomefolate Calcium Tablets, 3 mg/0.02 mg/0.451 mg and 0.451 mg

August 24, 2018 Lupin’s Nagpur facility receives Establishment Inspection Report (EIR) from US FDA

August 23, 2018 Lupin enters dermatology segment in Brazil with launch of Lupin High-End Skin Science

August 22, 2018 Lupin receives tentative FDA approval for generic Nudovra (Estradiol Valerate Tablets, 3 mg and 1 mg and Estradiol Valerate and Dienogest Tablets, 2 mg/2 mg and 2 mg/3 mg) Tablets

August 21, 2018 Lupin receives FDA approval for generic Hydrocortisone Butyrate Lotion, 0.1%

August 21, 2018 Lupin launches generic Clobetasol Propionate Cream USP 0.05% in the US

August 8, 2018 Quarter I, FY2019 – Results